The effects of progestins on bone density and bone metabolism in postmenopausal women: A randomized controlled trial

Estrogen remains the primary bone active agent in hormone therapy, while progestins have significantly less activity. The selection of the appropriate progestin in hormone therapy should be based on criteria other than bone activity.